CAR T therapy turns patient’s T-cells into cancer killers

FDA-approved treatment so new that many oncologists are unfamiliar with it

By , Daily Memphian Updated: May 26, 2019 10:45 AM CT | Published: May 25, 2019 5:50 PM CT

A new cancer treatment is giving lymphoma patients who are not responsive to chemotherapy another option than hospice care. 

Bluff City Biz

Sign up to get the latest news and analysis from our Business team.

Manage Your Email Subscriptions

Topics

cancer CAR T-cell therapy Dr. Salil Goorha Dr. Yasser Khaled Methodist Le Bonheur Healthcare
Michelle Corbet

Michelle Corbet

Michelle Corbet covers business for The Daily Memphian. Prior to, she was a reporter at the Memphis Business Journal. A native Memphian and University of Memphis graduate, Michelle covered business in Conway, Arkansas after college. Michelle got her start covering business as an intern at The Commercial Appeal.


Comment On This Story

Become a subscriber to join the discussion.
Bluff City Biz

Sign up to get the latest news and analysis from our Business team.

Manage Your Email Subscriptions